{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-052210","form_type":"8-K","ticker":"INDV","cik":"0001625297","company_name":"Indivior Pharmaceuticals, Inc.","filed_at":"2025-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.965941+00:00","generated_at":"2026-05-16T19:51:48.611494+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"confidence":"high","headline":"Indivior proposes re-domestication from UK to Delaware; shareholder vote set for Dec 11, 2025","bullets":["Scheme circular filed: EGM on Dec 11, 2025 to vote on re-domestication via scheme of arrangement.","New holding company would be Indivior Pharmaceuticals, Inc. (Delaware); shares to trade on Nasdaq.","Court approval and shareholder vote required; SEC registration exemption under Section 3(a)(10).","Indivior shares expected to cease trading on Nasdaq before effective date; new shares commence same day.","Board unanimously recommends voting in favor."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-052210","json":"https://secwatch.observer/filing/0001628280-25-052210.json","markdown":"https://secwatch.observer/filing/0001628280-25-052210.md","text":"https://secwatch.observer/filing/0001628280-25-052210.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625297/000162828025052210/0001628280-25-052210-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625297/000162828025052210/indv-20251114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T19:51:48.611494+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}